CompanyPfizer Europe MA EEIG
EU authorised2024-07-24
· 1 yr ago
Flags
Conditional approval
EMA EPAR
Evidence dossier ↗
Beqvez (previously Durveqtix) CONFIRMED
fidanacogene elaparvovec · Hemophilia B
Current stage: 4 · first detected 2026-06-25
Also known as: beqvez (previously durveqtix)
Status timeline
| Date | Body | Status | Stage | Source |
|---|---|---|---|---|
| 2026-06-25 | EMA | withdrawn | 4 | link |